These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14618816)

  • 1. [Results of long-term administration of propranolol to patients with ischemic heart disease].
    Bychko MV
    Lik Sprava; 2003; (5-6):93-5. PubMed ID: 14618816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined use of anaprilin and thiamine in the treatment of ischemic heart disease].
    Vodoevich VN; Vinogradova TA; Kulesh LD; Vinogradov VV
    Lik Sprava; 2003; (5-6):48-51. PubMed ID: 14618803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris].
    Butina EK; Kokurina EV; Dmitrieva NA; Bochkareva EV
    Ter Arkh; 2002; 74(9):36-41. PubMed ID: 12418118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The efficacy of proxodolol, a new beta-adrenoblockader with alpha-adrenoblockader properties, in its single use in patients with stable stenocardia of effort].
    Metelitsa VI; Martsevich SIu; Kozyreva MP; Slastnikova ID; Vakulovskaia MK
    Eksp Klin Farmakol; 1994; 57(3):47-50. PubMed ID: 7914121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Asymptomatic myocardial ischemia in the dynamics of anaprilin and korinfar treatment].
    Volkov VI; Ermakovich II; Strona VI
    Lik Sprava; 1997; (5):114-7. PubMed ID: 9491715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tolamolol versus propranolol on systolic time intervals in angina.
    Aronow WS; Vawter M; Spivack N; Warren M; Laverty W
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1069-76. PubMed ID: 4154826
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined therapy with beta-adrenergic blockers and calcium-antagonists in patients with ischemic heart disease.
    Winniford MD; Hillis LD
    Herz; 1982 Aug; 7(4):243-9. PubMed ID: 6127300
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative characteristics of the hemodynamic and antianginal actions of obzidan and albetol in patients with stenocardia].
    Zaĭtseva VI; Sharaeva ML
    Vrach Delo; 1988 Dec; (12):15-8. PubMed ID: 2907700
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of alpha-1 adrenergic blockade on the clinical course, immune status and blood plasma lipid spectrum in patients with ischemic heart disease].
    Lizogub VG; Chumak AA; Savchenko AV; Pliskevich DA
    Lik Sprava; 2000; (3-4):31-4. PubMed ID: 10921255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the action of beta-adrenergic blockers in the treatment of angina pectoris].
    de Mey D
    Acta Cardiol; 1972; ():Suppl 15:255-6. PubMed ID: 4147609
    [No Abstract]   [Full Text] [Related]  

  • 12. [Agents for the metabolic correction of myocardial energy metabolism in treating patients with ischemic heart disease].
    Vizyr AD; Kraĭdashenko OV; Berezin OIe; Oliĭnyk OI
    Lik Sprava; 2000 Mar; (2):26-30. PubMed ID: 10862469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina].
    Romakov AIu; Sagirov AM; Desiatnichenko VM; Sobol' IuS; Sumarokov AB
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):57-63. PubMed ID: 6139118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol for Angina Pectoris.
    Manu P; Rogozea LM
    Am J Ther; 2016; 23(6):e1285-e1286. PubMed ID: 27828838
    [No Abstract]   [Full Text] [Related]  

  • 15. [Disorders of myocardial contractile function and the mechanisms of their compensation in ischemic heart disease in man].
    Moĭbenko OO; Hryhorash HA; Kostylev MV
    Fiziol Zh (1994); 1995; 41(5-6):70-9. PubMed ID: 9026397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of acute administration of the levogyral beta-blocker levomoprolol on the exercise test in angina pectoris].
    Lai C; Tallu B; Onnis E; Pirisi R; Cioglia G; Cherchi A
    Cardiologia; 1984 Dec; 29(12):605-14. PubMed ID: 6152549
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperbaric oxygenation and antianginal preparations: the effect of a single combined use on the functional indices of the state of the heart in patients with angina pectoris].
    Seriakov VV; Efuni SN; Sidorenko BA
    Anesteziol Reanimatol; 1992; (2):9-13. PubMed ID: 1416216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of adrenergic beta blockers on hemodynamics, diastolic relaxation and distensibility of left-ventricular myocardium in patients with ischemic heart disease].
    Moroz VA; Gladchenko AR; Latoguz IK; Khimenko PL
    Klin Med (Mosk); 1991 Jan; 69(1):47-8. PubMed ID: 1673730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
    Johnston DL; Manyari DE; Kostuk WJ
    Can Med Assoc J; 1984 Jun; 130(11):1449-55. PubMed ID: 6145515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.